0001209191-18-021929.txt : 20180328
0001209191-18-021929.hdr.sgml : 20180328
20180328163846
ACCESSION NUMBER: 0001209191-18-021929
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180326
FILED AS OF DATE: 20180328
DATE AS OF CHANGE: 20180328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHROTRIYA RAJESH C MD
CENTRAL INDEX KEY: 0001193918
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35006
FILM NUMBER: 18719342
MAIL ADDRESS:
STREET 1: 157 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000831547
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930979187
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
BUSINESS PHONE: 702-835-6300
MAIL ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
FORMER COMPANY:
FORMER CONFORMED NAME: NEOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19960819
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICUS FUNDING CORP
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-26
0
0000831547
SPECTRUM PHARMACEUTICALS INC
SPPI
0001193918
SHROTRIYA RAJESH C MD
11500 S. EASTERN AVE.
SUITE 240
HENDERSON
NV
89052
1
0
0
0
Common Stock, $0.001 par value
2018-03-26
4
S
0
30000
17.34
D
1585963
I
By CS Family Trust
Common Stock, $0.001 par value
2018-03-27
4
S
0
30000
17.10
D
1555963
I
By CS Family Trust
Common Stock, $0.001 par value
2018-03-28
4
S
0
30000
16.19
D
1525963
I
By CS Family Trust
Common Stock, $0.001 par value
1787542
I
By Shrotriya Gift Trust
Common Stock, $0.001 par value
1243284
I
By RS Irrevocable Trust
Common Stock, $0.001 par value
28907
I
By 401(k) Plan
Common Stock, $0.001 par value
9523
I
By Spouse
Common Stock, $0.001 par value
67144
I
By Shrotriya Family Foundation
Common Stock, $0.001 par value
200652
D
All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 19, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.13 to $17.52, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.61 to $17.88, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.76 to $16.40, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ Kurt A. Gustafson, attorney-in-fact for Rajesh C. Shrotriya
2018-03-28